Acquirer(s)
- Australian Clinical Labs Limited
Target(s)
- Healius Limited
Australian Clinical Labs Limited (ACL) is seeking to acquire Healius Limited (Healius) by way of an off-market takeover offer to acquire all the fully paid ordinary shares in Healius.
ACL and Healius provide human pathology services to out-patients, in-patients (at public and private hospitals), and commercial and government customers, as well as veterinary pathology services. Healius also provides diagnostic imaging services.
Market inquiries
| Document title | Date | |
|---|---|---|
| ACL Healius - market inquiries letter |
Timeline
| Date | Event |
|---|---|
ACCC commenced review under the Merger Process Guidelines. |
|
Closing date for submissions. |
|
Former provisional date for announcement of ACCC’s findings (22 June) delayed at ACL’s request. ACCC will announce a revised provisional decision date in due course. |
Project staff
- Claudia Gulbransen-Diaz
- Lucia Moschis